US Stock MarketDetailed Quotes
GILD Gilead Sciences
- 94.350
- -2.680-2.76%
Close Nov 12 16:00 ET
- 94.500
- +0.150+0.16%
Post 18:54 ET
117.56BMarket Cap1048.33P/E (TTM)
96.840High94.225Low9.32MVolume96.350Open97.030Pre Close889.06MTurnover0.75%Turnover Ratio20.97P/E (Static)1.25BShares98.90052wk High6.39P/B117.34BFloat Cap60.75052wk Low3.06Dividend TTM1.24BShs Float98.900Historical High3.24%Div YieldTTM2.70%Amplitude0.405Historical Low95.366Avg Price1Lot Size
Gilead Sciences Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.02%7.55B | 5.36%6.95B | 5.26%6.69B | -0.60%27.12B | -3.72%7.11B | 0.11%7.05B | 5.42%6.6B | -3.61%6.35B | -0.09%27.28B | 2.00%7.39B |
| Operating revenue | 7.02%7.55B | 5.36%6.95B | 5.26%6.69B | -0.60%27.12B | -3.72%7.11B | 0.11%7.05B | 5.42%6.6B | -3.61%6.35B | -0.09%27.28B | 2.00%7.39B |
| Cost of revenue | 0.58%1.57B | 7.07%1.54B | 10.78%1.55B | 14.87%6.5B | 49.71%2.09B | 12.19%1.57B | 0.00%1.44B | -1.62%1.4B | -14.30%5.66B | -46.86%1.4B |
| Gross profit | 8.86%5.97B | 4.89%5.41B | 3.70%5.13B | -4.65%20.62B | -16.17%5.02B | -2.87%5.49B | 7.04%5.16B | -4.16%4.95B | 4.44%21.62B | 29.80%5.99B |
| Operating expense | 2.02%2.83B | -16.22%2.73B | 92.52%5.33B | 10.87%11.81B | 247.47%3.02B | 17.36%2.77B | 32.41%3.26B | -44.25%2.77B | 8.15%10.65B | -71.14%868M |
| Selling and administrative expenses | 8.97%1.43B | -25.53%1.38B | 4.25%1.38B | 7.35%6.09B | -20.40%1.61B | 8.41%1.32B | 36.26%1.85B | 21.79%1.32B | 8.14%5.67B | 22.42%2.02B |
| Research and development costs | -4.26%1.4B | -3.98%1.35B | 172.98%3.95B | 14.89%5.72B | 222.22%1.41B | 26.81%1.46B | 27.68%1.41B | -62.69%1.45B | 8.17%4.98B | -184.83%-1.15B |
| Operating profit | 15.85%3.14B | 41.03%2.68B | -108.74%-191M | -19.72%8.81B | -60.82%2.01B | -17.41%2.71B | -19.42%1.9B | 965.85%2.19B | 1.08%10.97B | 218.52%5.13B |
| Net non-operating interest income expense | -2.59%-238M | -3.04%-237M | -10.43%-254M | -0.96%-944M | -11.50%-252M | -1.31%-232M | 4.96%-230M | 3.36%-230M | 6.59%-935M | 5.04%-226M |
| Non-operating interest expense | 2.59%238M | 3.04%237M | 10.43%254M | 0.96%944M | 11.50%252M | 1.31%232M | -4.96%230M | -3.36%230M | -6.59%935M | -5.04%226M |
| Other net income (expense) | -1,095.71%-1.95B | -367.86%-393M | -516.79%-4.04B | 76.17%-1.01B | 96.37%-104M | 73.88%-163M | 86.32%-84M | -450.42%-655M | -167.74%-4.23B | -368.63%-2.87B |
| Special income (charges) | -2,378.02%-2.26B | 83.90%-38M | -758.84%-4.13B | 66.93%-1.21B | 86.11%-397M | 79.69%-91M | 28.48%-236M | -5,912.50%-481M | -288.07%-3.64B | -327.20%-2.86B |
| -Less:Other special charges | 454.95%505M | -83.90%38M | 758.84%4.13B | 22.35%1.16B | 119.62%347M | -79.69%91M | -28.48%236M | 5,912.50%481M | 0.53%944M | -76.38%158M |
| -Write off | --1.75B | --0 | ---- | -98.15%50M | ---- | ---- | --0 | ---- | --2.7B | ---- |
| Other non- operating income (expenses) | 525.00%306M | -333.55%-355M | 152.30%91M | 134.08%198M | 3,030.00%293M | 59.09%-72M | 153.52%152M | -56.76%-174M | 9.08%-581M | -117.54%-10M |
| Income before tax | -58.76%956M | 29.28%2.05B | -445.08%-4.49B | 17.97%6.86B | -18.61%1.65B | -4.69%2.32B | 5.66%1.59B | 955.26%1.3B | -29.77%5.81B | 167.59%2.03B |
| Income tax | -303.42%-297M | -20.22%438M | -199.68%-315M | -0.08%1.25B | -40.45%237M | -77.40%146M | 49.18%549M | 292.68%316M | -39.91%1.25B | 3.92%398M |
| Net income | -42.31%1.25B | 55.34%1.61B | -523.35%-4.17B | 22.93%5.61B | -13.23%1.42B | 21.61%2.17B | -8.46%1.04B | 8,108.33%985M | -26.37%4.57B | 334.31%1.63B |
| Net income continuous Operations | -42.31%1.25B | 55.44%1.62B | -523.88%-4.17B | 22.91%5.61B | -13.29%1.42B | 21.61%2.17B | -8.46%1.04B | 8,100.00%984M | -26.37%4.57B | 334.31%1.63B |
| Minority interest income | 0 | 0 | 0 | -100.00%-52M | -71.43%-12M | -166.67%-8M | 33.33%-6M | -271.43%-26M | -8.33%-26M | -16.67%-7M |
| Net income attributable to the parent company | -42.52%1.25B | 54.45%1.61B | -512.87%-4.17B | 23.37%5.67B | -12.87%1.43B | 21.86%2.18B | -8.65%1.05B | 5,215.79%1.01B | -26.23%4.59B | 329.32%1.64B |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -42.52%1.25B | 54.45%1.61B | -512.87%-4.17B | 23.37%5.67B | -12.87%1.43B | 21.86%2.18B | -8.65%1.05B | 5,215.79%1.01B | -26.23%4.59B | 329.32%1.64B |
| Basic earnings per share | -42.86%1 | 53.57%1.29 | -512.35%-3.34 | 24.04%4.54 | -12.21%1.15 | 22.38%1.75 | -7.69%0.84 | 3,950.00%0.81 | -26.21%3.66 | 336.67%1.31 |
| Diluted earnings per share | -42.20%1 | 55.42%1.29 | -517.50%-3.34 | 23.63%4.5 | -12.31%1.14 | 21.83%1.73 | -8.79%0.83 | 3,900.00%0.8 | -26.17%3.64 | 333.33%1.3 |
| Dividend per share | 2.67%0.77 | 2.67%0.77 | 2.67%0.77 | 2.74%3 | 2.74%0.75 | 2.74%0.75 | 2.74%0.75 | 2.74%0.75 | 2.82%2.92 | 2.82%0.73 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
